The Diazole Rings Are Bonded Directly To Each Other Patents (Class 548/313.4)
  • Publication number: 20150148442
    Abstract: A photopolymerization method in which an ink composition including (A) a polymerizing compound having an ethylenic unsaturated group, (B) a photopolymerization initiator represented by Formula (1) described below, and (C) a hydrogen donor having a structure in which a nitrogen atom is directly bonded to an aromatic ring, in which the aromatic ring has an electron-withdrawing group or the nitrogen atom constitutes a hetero ring, is photopolymerized under acidic conditions, in Formula (1), each of R1 to R30 represents a hydrogen atom, a halogen atom, an alkyl group, or an alkoxy group.
    Type: Application
    Filed: February 2, 2015
    Publication date: May 28, 2015
    Applicant: FUJIFILM CORPORATION
    Inventor: Katsuyuki YOFU
  • Patent number: 8697886
    Abstract: According to the present invention, unstable hydrogen of 4,4?,5,5?-tetranitro-2,2?-biimidazole, which is a promising material for insensitive high-performance molecular explosives, may be stabilized by aminoguanidium to provide di(aminoguanidium) 4,4?,5,5?-tetranitro-2,2?-biimidazole, thereby solving the hygroscopicity of 4,4?,5,5?-tetranitro-2,2?-biimidazole, and enhancing performance and insensitivity thereof.
    Type: Grant
    Filed: February 2, 2012
    Date of Patent: April 15, 2014
    Assignee: Agency for Defense Development
    Inventors: Jin Seuk Kim, Seung Hee Kim, Hyoun Soo Kim
  • Publication number: 20130331328
    Abstract: Small molecule inhibitors of AGBL2 are provided, as well as methods of using the inhibitors to treat or prevent cancer and neurologic disorders.
    Type: Application
    Filed: February 14, 2012
    Publication date: December 12, 2013
    Applicant: GEORGETOWN UNIVERSITY
    Inventors: Stephen W. Byers, Sivanesan Dakshanamurthy, Ziad Sahab
  • Patent number: 8460581
    Abstract: The present invention relates to imidazole derivatives and their use as dopants for doping an organic semiconductor matrix material, organic semiconductor materials and electronic or optoelectronic structural elements.
    Type: Grant
    Filed: May 9, 2008
    Date of Patent: June 11, 2013
    Assignee: Novaled AG
    Inventors: Horst Hartmann, Olaf Zeika, Martin Ammann, Rene Dathe
  • Publication number: 20120261650
    Abstract: An organic electroluminescent device comprising: a pair of electrodes comprising an anode and a cathode, and one or more layers arranged between the anode and the cathode; wherein at least one of the one or more layers is a light emitting layer and wherein the one or more layers, comprises an organic compound represented by a substituted 2,2?-biimidazole.
    Type: Application
    Filed: October 21, 2011
    Publication date: October 18, 2012
    Applicant: Commonwealth Scientific and Industrial Research Organisation
    Inventors: James Matthew MacDonald, Mark Bown, Kazunori Ueno, Karl Peter Weber, Jenny Lee O'Connell, Tadahiko Hirai
  • Publication number: 20120203008
    Abstract: According to the present invention, unstable hydrogen of 4,4?,5,5?-tetranitro-2,2?-biimidazole, which is a promising material for insensitive high-performance molecular explosives, may be stabilized by aminoguanidium to provide di(aminoguanidium) 4,4?,5,5?-tetranitro-2,2?-biimidazole, thereby solving the hygroscopicity of 4,4?,5,5?-tetranitro-2,2?-biimidazole, and enhancing performance and insensitivity thereof.
    Type: Application
    Filed: February 2, 2012
    Publication date: August 9, 2012
    Applicant: Agency for Defense Development
    Inventors: Jin Seuk Kim, Seung Hee Kim, Hyoun Soo Kim
  • Patent number: 7993886
    Abstract: The claimed invention relates to a process for preparing (meth)acrylates of N-hydroxyalkylated amides, in which open-chain N-hydroxyalkylated amides are esterified with (meth)acrylic acid or transesterified with at least one (meth)acrylic ester in the presence of at least one heterogeneous catalyst selected from the group consisting of an inorganic salt and an enzyme.
    Type: Grant
    Filed: July 16, 2010
    Date of Patent: August 9, 2011
    Assignee: BASF Aktiengesellshaft
    Inventors: Frank Hoefer, Dietmar Haering
  • Publication number: 20110045101
    Abstract: Disclosed are compounds of Formula 1, including all geometric and stereoisomers, N-oxides, and salts thereof, wherein J is Q2 or R1; X is N, CR2 or CQ3; Y is N or CR3; Z is N or CR4; and Q1, Q2, Q3, R1 R2 and R3 are as defined in the disclosure. Also disclosed are compositions containing the compounds of Formula 1 and methods for controlling plant disease caused by a fungal pathogen comprising applying an effective amount of a compound or a composition of the invention.
    Type: Application
    Filed: May 7, 2009
    Publication date: February 24, 2011
    Applicant: E.I. Du Pont De Nemours and Company
    Inventors: Thomas Paul Selby, James Francis Bereznak, John Joseph Bisaha, Amy X. Ding, Mary Ann Hanagan, Jeffrey Keith Long, Andrew Edmund Taggi, Vijayagopal Gopalsamuthiram
  • Publication number: 20100301277
    Abstract: The present invention relates to imidazole derivatives and their use as dopants for doping an organic semiconductor matrix material, organic semiconductor materials and electronic or optoelectronic structural elements.
    Type: Application
    Filed: May 9, 2008
    Publication date: December 2, 2010
    Applicant: NOVALED AG
    Inventors: Horst Hartmann, Olaf Zeika, Martin Ammann, Rene Dathe
  • Patent number: 7825142
    Abstract: Heterocyclic compounds, compositions comprising them, and methods of their use for the treatment, prevention and management of inflammatory and autoimmune diseases and disorders are disclosed.
    Type: Grant
    Filed: August 24, 2009
    Date of Patent: November 2, 2010
    Assignee: Lexicon Pharmaceuticals, Inc.
    Inventors: David J. Augeri, Jeffrey Bagdanoff, Simon D. P. Baugh, Kenneth G. Carson, Theodore C. Jessop, James E. Tarver
  • Patent number: 7816485
    Abstract: Process for catalytically preparing (meth)acrylates of N-hydroxyalkylated amides and use thereof.
    Type: Grant
    Filed: June 30, 2005
    Date of Patent: October 19, 2010
    Assignee: BASF Aktiengesellschaft
    Inventors: Frank Hoeffer, Dietmar Haering
  • Patent number: 7598280
    Abstract: Heterocyclic compounds, compositions comprising them, and methods of their use for the treatment, prevention and management of inflammatory and autoimmune diseases and disorders are disclosed.
    Type: Grant
    Filed: February 28, 2008
    Date of Patent: October 6, 2009
    Assignee: Lexicon Pharmaceuticals, Inc.
    Inventors: David J. Augeri, Jeffrey Bagdanoff, Simon D. P. Baugh, Kenneth G. Carson, Theodore C. Jessop, James E. Tarver
  • Patent number: 7078528
    Abstract: Biimidazole diamide compounds that are useful for binding anions such as sulfate are described, along with the use thereof for purposes such as extracting anions from a waste stream and/or detecting anions.
    Type: Grant
    Filed: July 2, 2003
    Date of Patent: July 18, 2006
    Assignee: East Carolina University
    Inventors: William E. Allen, Corey P. Causey
  • Patent number: 6713631
    Abstract: Disclosed is a preparation method of 2,2′-bi-1H-imidazole using glyoxal and an ammonium salt as starting materials through a safe, simple and easily controlled synthetic process with a high yield.
    Type: Grant
    Filed: March 6, 2003
    Date of Patent: March 30, 2004
    Assignee: Agency for Defense Development
    Inventors: Jin Rai Cho, Soo Gyeong Cho, Eun Mee Goh, Jae Kyung Kim
  • Patent number: 6448286
    Abstract: The current invention discloses useful pharmaceutical compositions containing amidino derivative useful as nitric oxide synthase inhibitors.
    Type: Grant
    Filed: July 28, 1998
    Date of Patent: September 10, 2002
    Assignee: G.D. Searle & Co.
    Inventors: Donald W. Hansen, Jr., Mark G. Currie, E. Ann Hallinan, Kam F. Fok, Timothy J. Hagen, Arija A. Bergmanis, Steven W. Kramer, Len F. Lee, Suzanne Metz, William M. Moore, Karen B. Peterson, Barnett S. Pitzele, Dale P. Spangler, R. Keith Webber, Mihaly V. Toth, Mahima Trivedi, Foe S. Tjoeng